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Abstract 
Vascular aging is a major contributor to cardiovascular disease, and can be quantified by 
higher carotid stiffness, intima-media thickness and diameter, and hypertension. Weight gain 
across the lifetime may be an important, modifiable determinant of vascular aging. We 
therefore aimed to assess lifetime body silhouette trajectories (a marker of weight change 
across the lifespan) in relation to vascular aging in late adulthood. We used cross-sectional 
data from a community-based cohort study (n=8,243/age 59.4/38.7% women). A linear mixed 
model was used to assess trajectories of recalled body silhouettes from age 8-45. We assessed 
carotid artery properties (ultrasonography), resting hypertension (blood pressure 
≥140/90 mmHg or use of antihypertensives), and exaggerated exercise blood pressure, a 
marker of masked hypertension (systolic blood pressure ≥150 mmHg during submaximal 
exercise) at study recruitment when the participants were aged 50 to 75. We identified five 
distinct body silhouette trajectories: lean-stable (32.0%), lean-increase (11.1%), moderate-
stable (32.5%), lean-marked increase (16.3%) and heavy-stable (8.1%). Compared to 
individuals in the lean-stable trajectory, those in the moderate-stable, lean-marked increase 
and heavy-stable trajectories had higher carotid stiffness, intima-media thickness and 
diameter (odds ratios between 1.23-2.10 for highest quartile vs. lowest quartile of 
manifestations of vascular aging, P<.05), and were more likely to have resting hypertension 
and exaggerated exercise blood pressure, after adjustment for potential confounders (odds 
ratios between 1.31-1.60, P<.05). Vascular aging was most prominent among individuals who 
were lean in early life but markedly gained weight during young adulthood, and among those 
who were heavy in early life and maintained weight.  
 
Keywords. arterial stiffness, intima-media thickness, hypertension, adiposity, life course 
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Introduction 
Vascular aging, i.e. accumulation of functional and structural changes of vessels throughout 
life, is a major contributor to cardiovascular disease.1 Key manifestations of vascular aging 
include arterial stiffening, higher carotid intima-media thickness (IMT), carotid diameter 
enlargement, and higher blood pressure (BP) at rest (resting hypertension) or during exercise 
(exaggerated exercise BP, a marker of masked hypertension that is otherwise missed by 
resting BP values2). These manifestations have all been associated with incident 
cardiovascular disease.2-5 Beyond the effect of age, vascular aging can be accelerated by 
exposure to poor lifestyle across the lifespan, and, thus, may be a partly modifiable process.6  
 
Given the global burden of obesity, understanding the effect of adiposity on vascular aging is 
of critical importance. Evidence is currently incomplete, as most previous studies,7-15 but not 
all,16 have focused on adiposity only at specific age periods, i.e. adulthood7-12 or 
childhood/adolescence into young adulthood.13-15 Adiposity is, however, a dynamic and 
changing process starting early in life, i.e. body mass index typically increases with age, in 
particularly in young adulthood,17 and childhood obesity is often tracked into adulthood.18 A 
life course approach is, therefore, crucial to study the effect of adiposity on vascular aging. 
This will help to develop effective prevention strategies targeting the life period at which 
adiposity has a predominant influence on vascular health.6 
 
Recalled body silhouettes at different ages have a moderate to good correlation with 
objectively measured adiposity at these different ages (see supplemental material Table S1 for 
a summary of previous studies).19-22 By combining recall of body silhouettes at different ages 
it is possible to construct body silhouette trajectories over the life course.23 Using this 
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approach, body silhouettes trajectories have been shown to be associated with a higher 
incidence of type 2 diabetes24, 25 and cardiovascular disease,25 and higher mortality.23  
 
We therefore calculated body silhouettes trajectories over the life course using self-recalled 
body silhouettes from age 8 up to 45 and quantified their association with vascular aging in 
late adulthood.  
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Methods 
Data are available on request subject to approval by the Paris Prospective Study 3 (PPS3) 
scientific committee. 
 
Study population 
The PPS3 (n=10,157) is a community-based cohort study on novel markers for phenotypes of 
cardiovascular disease, as described previously.26 In brief, individuals aged between 50-75 
years were recruited at the Centre d’Investigations Préventives et Cliniques, a large preventive 
medical center in Paris (France), between June, 2008 and June, 2012. The Ethics Committee 
of the Cochin Hospital (Paris, France) approved the study. PPS3 was registered in the World 
Health Organization international clinical trial registry platform (NCT00741728). 
 
Body silhouettes 
We used body silhouettes adapted from Stunkard et al.27 At study recruitment, participants 
self-reported one of the seven pictorial body diagrams (somatotypes) (Figure 1) that best 
depicted their body silhouette at ages 8, 15, 25, 35 and 45 years.  
 
Manifestations of vascular aging 
Carotid stiffness, IMT and diameter 
Carotid stiffness (i.e. carotid distensibility coefficient [DC] and Young’s elastic modulus, 
[YEM]), IMT and diameter were determined using high-resolution echotracking as described 
previously and further detailed in the online supplemental material.28 Carotid DC represents 
arterial stiffness and carotid YEM the stiffness of the arterial wall material at operating 
pressure. Please note that lower values of carotid DC, but higher values of carotid YEM 
reflect greater arterial stiffness.  
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Resting hypertension and exaggerated exercise BP 
Resting BP was recorded in triplicate using an Omron 705 C oscillometric device and an 
appropriate sized cuff after 10 min of supine rest, as described previously.29 The mean of the 
last two measurements were used in the analysis. Resting hypertension was defined by a BP 
of ≥140/90 mmHg and/or use of antihypertensive medication. In addition, BP was measured 
during a submaximal exercise step test.29 After the resting BP measurements, participants 
performed the step test with the BP cuff left in situ to enable recording of one BP 
measurement in the shortest time immediately after participants had stopped exercise. The 
exercise test consisted of stepping up and down two steps for 2 min at your own pace. 
Exaggerated exercise BP was defined as an exercise systolic BP ≥150 mmHg irrespective of 
the use of antihypertensive medication.29   
 
Covariates 
A self-administered questionnaire was used to obtain information on education level, smoking 
behavior (never, former and current), depressive symptoms, physical activity, medication use, 
medical history, birth weight (categories <2.5 kg, 2.5-4 kg, and >4kg; data on exact birth 
weight were not available) and dietary habits. We divided education level into three 
categories: 1) low (no or primary education); 2) intermediate (secondary education), and 3) 
high (higher education or university). The validated Baecke score was used to estimate overall 
physical activity (higher scores indicating higher levels of physical activity).30 Dietary habits 
were evaluated using a semi-quantitative 18-item food frequency questionnaire.31 We 
considered the following dietary habits, as defined previously31: habitual breakfast (complete 
breakfast vs. no complete breakfast), consumption of fish/week (>4 times vs. ≤3 times), 
consumption of fresh fruit/week (>4 times vs. ≤3 times) and consumption of vegetables/week 
(>4 times vs. ≤3 times). Depression symptoms were assessed using the 13-items 
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Questionnaire of Depression 2nd version, Abridged (QD2A).32 We defined the presence of 
depressive symptoms by a QD2A score ≥7 or use of antidepressant medication. Prior 
cardiovascular disease was defined by a self-reported history of stroke, myocardial infarction 
and/or angina pectoris, and diabetes by use of glucose-lowering medication or a fasting blood 
glucose ≥7 mmol/L.  
 
Analytical sample 
Of the 10,157 participants, 539 individuals (5.3%) had missing data on body silhouettes at all 
ages, 95 (0.9%) on four ages, 150 on three ages (1.5%), 138 (1.4%) on two ages and 533 
(5.2%) on one age. A total of 8,702 (85.7%) individuals had no missing data. We calculated 
the trajectories in all individuals (n=9,020, 88.8%) with available data on body silhouettes on 
≥three out of the five ages and including the earliest (8 years) and the latest age (45 years). In 
addition, 777 individuals had missing data on manifestations of vascular aging. The final 
study sample therefore consisted of 8,243 individuals. Excluded participants as compared to 
those included in the present analysis had a more unfavorable cardiovascular risk profile (see 
online supplemental material).  
 
Statistical analysis 
Analyses were performed using SAS version 9.4. The percentage of missing values with 
regard to potential confounders was minimal (maximum, 3.0%). We imputed these data using 
multiple imputations by chained equations (5 data sets). We used a group-based trajectory 
modeling approach implemented by SAS Proc Traj and as described in the online 
supplemental material (expanded methods section, Tables S2-S4 and Figures S1-S2).33 We 
identified five body silhouette trajectories based on the change in the Bayesian information 
criterion, and classified them based on their visual appearance, i.e. lean-stable, lean-increase, 
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lean-marked increase, moderate-stable and heavy-stable. We then calculated the posterior 
probability for each participant being a member of one of the five trajectories and assigned 
each participant into the trajectory to which their posterior probability was greatest. The 
average posterior probability for each trajectory ranged between 82%-90% indicating good 
allocation of individuals to the trajectories.33 Trajectories were initially calculated stratified by 
sex, but trajectories were almost identical for men and women. Hence, the trajectories are 
described without stratification by sex. 
 
We used multinomial logistic regression to evaluate associations between body silhouette 
trajectories and quartiles of carotid DC, YEM, IMT and diameter, and logistic regression to 
evaluate associations with resting hypertension and exaggerated exercise BP. We used the 
lean-stable group as the reference category in all analyses. We modeled carotid DC, YEM, 
IMT and diameter on a categorical scale, because such categorization provides results that are 
easier to interpret (odds ratios). We used ordinal regression analyses to test the proportional 
odds assumption, i.e. whether or not there is a graded association between body silhouette 
trajectories and manifestations of vascular aging. In addition, we used linear regression to 
evaluate the association between body trajectories and continuous values of carotid DC, 
YEM, IMT and diameter and resting and exercise systolic BP. We adjusted for the following 
potential confounders based on previous literature10, 13-15, 34: age, sex (only in analyses without 
sex-specific quartiles as the outcome), height, education, smoking, physical activity, dietary 
habits, heart rate, prior cardiovascular disease, diabetes, depressive symptoms and use of 
lipid-modifying medication. Analyses with carotid DC, YEM, IMT and diameter as the 
outcome were also adjusted for mean arterial pressure and use of antihypertensive medication.  
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We did several additional analyses: 1) we additionally adjusted the results for birth weight to 
test whether any of the tested associations could be explained by fetal growth; 2) to address 
residual confounding, we adjusted for cardiorespiratory fitness (as estimated by the validated 
NET-F algorithm29) instead of physical activity, and we adjusted for fasting glucose instead of 
diabetes; 3) to address possible reverse causality, we repeated the analyses after excluding 
individuals with prior cardiovascular disease; 4) we repeated the analyses after excluding 
individuals whose trajectory assignment probability was <80%; 5) we stratified the analyses 
by age categories (≤55 years, 55-65 years and >65 years) to evaluate whether associations 
were different according to the time difference between latest age of recalled body silhouette 
(45 years) and age at which vascular measurements were done; 6) we stratified the analyses 
by smoking behavior (never, current and former), because previous studies23 have suggested 
that the association between body silhouette and mortality differs according to smoking 
status; 7) we stratified the analysis according to resting BP (<140/90 mmHg and ≥140/90 
mmHg); 8) we additionally adjusted for current waist circumference or BMI to evaluate 
whether body silhouette trajectories may have any additional value in the association with 
vascular aging beyond measures of current adiposity; and 9) to evaluate the importance of 
increase of adiposity over the lifetime, we calculated the difference between the lean-marked 
increase trajectory on the one hand and the heavy-stable and moderate-stable trajectory on the 
other with regard to their association with manifestations of vascular aging. 
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Results 
 
Body silhouette trajectories and study characteristics  
We identified five distinct trajectories of body silhouette (Figure 2). Overall, 32.0% (n=2,641) 
of the participants maintained a lean body shape from age 8 until 45 (lean-stable group); 
11.1% (n=917) started lean and then had a moderate increase in body shape (lean-increase); 
32.5% (n=2,677) had a medium body shape and maintained weight (moderate-stable); 16.3% 
(n=1,340) started lean and then had a substantial gain of weight (lean-marked increase); and 
8.1% (n=668) started heavy and maintained weight (heavy-stable). Characteristics of the total 
study population and according to body silhouette trajectory are shown in Table 1.  
 
Association with manifestations of vascular aging 
Individuals in the trajectories moderate-stable, lean-marked increase and heavy-stable 
compared to those in the lean-stable trajectory had higher odds of having a lower carotid DC, 
higher YEM, higher IMT and higher diameter (Figure 3 and Table 2). In addition, individuals 
in the trajectories lean-increase, moderate-stable, lean-marked increase and heavy-stable 
compared to those in the lean-stable trajectory had higher odds of having resting hypertension 
and exaggerated exercise BP (Figure 3 and Table 2). The results of the ordinal regression 
analysis showed that the proportional assumption was met for all analyses, except for the 
analyses with carotid diameter as the outcome (supplemental material, Table S5). When 
carotid DC, YEM, IMT and diameter, and resting and exercise systolic BP were modeled as 
continuous variables, results were qualitatively similar (Table 3). 
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Additional analyses 
Results did not materially change when we additionally adjusted for birth weight (Table S6) 
cardiorespiratory fitness (Table S7), fasting glucose (Table S8), or after excluding individuals 
with prior cardiovascular disease (n=171) (Table S9). In addition, when we repeated the 
analyses after excluding individuals whose trajectory assignment probability was <80% 
(n=2,209), effect estimates for the associations between body trajectories and manifestations 
of vascular aging became higher (Table S10). Furthermore, results were qualitatively similar 
in individuals aged ≤55, 55-65 and >65 years (Table S11), and in never, former and current 
smokers (Table S12). Body silhouette trajectories were associated with carotid DC, YEM, 
IMT and diameter, and exaggerated exercise BP irrespective of resting BP category (Table 
S13). Adjustments for current waist circumference (Table S14) or BMI (Table S15) 
attenuated the associations between body silhouette trajectories and manifestations of vascular 
aging. The attenuation was less for the lean marked-increase than for the heavy-stable 
trajectory. Some body silhouette trajectories, most often moderate-stable and lean-marked 
increase, remained statistically significantly associated with some manifestations of vascular 
aging. Finally, the lean-marked increase trajectory, as compared to the moderate-stable 
trajectory, had a statistically significantly higher odds of some manifestations of vascular 
aging (i.e. greater carotid IMT and diameter and exaggerated exercise BP) (Table S16). There 
were no differences between the lean-marked increase and heavy-stable trajectory (Table 
S16). 
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Discussion 
We evaluated the association between recalled body silhouettes over the lifespan and various 
manifestations of vascular aging in late adulthood. We found that participants who remained 
heavy from 8 to 45 years and even those who were lean in childhood but gained weight in 
young adulthood had the highest values of carotid stiffness, IMT and diameter, and highest 
odds of resting hypertension and exaggerated exercise BP, indicating evidence of advanced 
vascular aging. In contrast, those who maintained a stable-lean body silhouette had the lowest 
values of carotid stiffness, IMT and diameter, and lowest odds of resting hypertension and 
exaggerated exercise BP. These findings suggest that prevention of weight gain across the life 
course, in particular in young adulthood, is important to promote healthy vascular aging. 
 
One previous study16 retrospectively linked BMI measured in childhood and from an age of 
36 to 60-64 years to carotid IMT and BP measured at an age of 60-64 years. This study found 
that in particular individuals that remained overweight from 36 to 60-64 years as compared to 
those without overweight during this time period had higher carotid IMT and systolic BP at 
an age of 60-64 years. We extend these results by investigating trajectories of adiposity across 
a wider age range and by investigating a larger number of manifestations of vascular aging. In 
our study, a marked increase in weight during young adulthood as compared to maintaining a 
lean weight was associated with a 0.9 kPa/103 lower carotid DC and 20 μm higher carotid 
IMT, which is equivalent to approximately 5 years of normal aging.35, 36 
 
Some methodological issues warrant consideration. First, body silhouettes may represent an 
alternative to objectively and repeatedly measured adiposity manifestations across the life 
course in large observational studies when lifetime objective adiposity measures are not 
available.26-28 However, some previous studies21, 37 found a systematic bias in reporting of 
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body silhouettes: individuals with low BMI tended to overestimate their body size, whereas 
those with normal or high BMI tended to underestimate their body size. This may have led to 
an underestimation of the associations between body silhouette trajectories and manifestations 
of vascular aging. Confirmation of our results in a longitudinal study that prospectively 
evaluates adiposity over the life course would therefore be ideal. Second, we evaluated 
whether the associations between body trajectories and vascular aging were independent of 
BMI and waist circumference in late adulthood. However, these analyses should be 
interpreted with caution because adjustment for adiposity in late adulthood is likely to be an 
overadjustment, i.e. such adjustment controls not only for adult body size, but also for change 
in body weight across the life course. Furthermore, adulthood adiposity is likely to be on the 
causal path from childhood adiposity to accelerated vascular aging.23 Nevertheless, these 
analyses showed that trajectories moderate-stable, lean-marked increase and heavy-stable 
remained statistically significantly associated with some manifestations of vascular aging. 
Furthermore, the attenuation was less for the lean marked-increase trajectory than for the 
heavy-stable trajectory. This may suggest that body trajectories can have additional predictive 
value beyond current objective measures of adiposity, in particular the lean-marked increase 
trajectory, but future prospective studies are needed to address this issue. Third, additional 
analyses suggested that increase in adiposity over the life time (i.e. lean-marked increase 
trajectory) may be at least as strongly associated with vascular aging as accumulation of high 
adiposity (i.e. moderate-stable and heavy-stable trajectories). However, these analyses should 
also be interpreted with caution, because of risk of false-positive findings due to multiple 
testing.  
 
Several mechanisms may underlie the association between life course adiposity and vascular 
aging. Weight gain in young adulthood has been associated with sympathetic overactivity, 
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insulin resistance, low-grade inflammation, and lower adiponectin and higher leptin levels.38 
These factors may accelerate age-related fragmentation and depletion of elastin and 
deposition of collagen in the vascular media, thickening of the media layer, and compensatory 
arterial remodeling.1 Ultimately, this may manifest as advanced vascular aging. In addition, 
body silhouette trajectories were associated with higher carotid stiffness, IMT and diameter 
and exaggerated exercise BP even in individuals with normal resting BP, suggesting that the 
effect of body adiposity on vascular aging is not only explained by increased resting BP. This 
is also in accordance with exaggerated exercise BP being associated with incident 
cardiovascular disease and mortality even among people with apparently controlled resting 
BP.2  
 
Strengths of the present study include the detailed phenotypes of carotid artery properties in a 
large sample size with core-lab centralized reading. Furthermore, we were able to study 
various manifestations of vascular aging which enabled us to test the consistency of our 
associations. 
 
The present study has several limitations. First, we did not have information about long-term 
lifestyle patterns including physical activity and dietary habits. These patterns may in part 
explain the observed findings. Second, the derived body silhouette trajectories are data driven, 
and may, therefore, vary by cohort. Third, birth weight was self-reported, which is less 
accurate than actual birth weight. Finally, no data were available on insulin resistance. Insulin 
resistance may partly explain the association between body silhouette trajectories and 
vascular aging. 
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In conclusion, a life course approach enables identification of body silhouette trajectories 
from age 8 up to 45 that are associated with vascular aging. Vascular aging was most 
prominent among individuals who were lean in early life but gained weight during young 
adulthood, and among those who were heavy in early life and maintained a heavy weight.  
 
Perspectives 
The present study results suggest that healthy behaviors and environments to prevent weight 
gain across the life course, especially during young adulthood, are important to promote 
healthy vascular aging. Future studies should investigate determinants of lifetime trajectories 
of body silhouettes for development of strategies to promote healthy vascular aging.  
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Novelty and significance 
1- What is new?  
• The association between adiposity over the life course and vascular aging in late 
adulthood is unknown.  
2- What is relevant? 
• Weight gain across the lifetime may be an important, modifiable determinant of vascular 
aging. 
3- Summary 
• We used a novel method to estimate adiposity trajectories across the life course using 
recalled body silhouettes from age 8 up to 45. 
• Vascular aging was most prominent among individuals who were lean in early life but 
markedly gained weight during young adulthood, and among those who were heavy in 
early life and maintained weight. 
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Figure Legends 
Figure 1. Body silhouettes. Body silhouettes for women and men in adults.  
 
Figure 2. Trajectories of body silhouettes. Trajectories of body shape by age in women and 
men combined. Mean body shape levels on y-axis were estimated from trajectory models. 
Percentages represent the proportion of the study population in each trajectory.  
 
Figure 3. Associations between body silhouette trajectories and manifestations of 
vascular aging: carotid distensibility coefficient (DC; quartile 1 vs. quartile 4); carotid 
Young’s elastic modulus (YEM; quartile 4 vs. quartile 1); carotid intima-media thickness 
(IMT; quartile 4 vs. quartile 1); carotid diameter (quartile 4 vs. quartile 1); resting 
hypertension (blood pressure ≥140/90 mmHg or use of antihypertensive medication); and 
exaggerated exercise blood pressure (exercise BP; exercise systolic BP ≥150 mmHg). The 
lean-stable group served as the reference group in all analyses. Results are adjusted for age, 
sex (only in analyses without sex-specific quartiles as the outcome), height, education, 
smoking, physical activity, dietary habits, heart rate, prior cardiovascular disease, diabetes, 
depressive symptoms and use of lipid-modifying medication. Analyses with carotid DC, 
YEM, IMT and diameter as outcome were also adjusted for mean arterial pressure and use of 
antihypertensive medication. For cut-off values of sex-specific quartiles of carotid artery 
properties, see the online supplemental material.  
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Table 1. Characteristics for the total study population and according to body silhouette trajectory* 
Study population characteristics Total study 
population 
Body silhouette trajectory 
  Lean-stable 
 
Lean-increase 
 
Moderate-
stable 
 
Lean-marked 
increase 
Heavy-stable 
 
 n=8,243 32.0%; 
n=2,641 
11.1%; n=917 32.5%; 
n=2,677 
16.3%; 
n=1,340 
8.1%; n=668 
General characteristics       
Age (years) 59.4 (6.2) 59.4 (6.1) 60.3 (6.4) 59.3 (6.3) 59.2 (6.3) 58.8 (5.9) 
Men 61.3 (5,057) 61.6 (1,626) 71.5 (656) 55.3 (1,481) 74.0 (991) 45.4 (303) 
Education 
   Low 
   Middle 
   High 
 
27.7 (2,281) 
30.2 (2,490) 
41.2 (3,393) 
 
24.3 (643) 
31.3 (827) 
43.2 (1,140) 
 
28.2 (259) 
27.5 (252) 
43.0 (394) 
 
26.5 (710) 
30.8 (825) 
41.8 (1,119) 
 
34.1 (457) 
29.4 (394) 
36.0 (482) 
 
31.7 (212) 
28.7 (192) 
38.6 (258) 
Smoking       
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   Current 
   Former 
   Never 
14.4 (1,190) 
33.8 (2,790) 
51.5 (4,247) 
13.4 (353) 
32.7 (863) 
53.9 (1,419) 
14.3 (131) 
35.8 (328) 
49.7 (456) 
15.6 (418) 
32.8 (877) 
51.5 (1,378) 
13.2 (177) 
37.9 (508) 
48.7 (653) 
16.6 (111) 
32.0 (214) 
51.0 (341) 
Prior cardiovascular disease 1.8 (151) 1.3 (35) 2.2 (20) 2.0 (54) 2.3 (31) 1.6 (11) 
Diabetes 3.7 (302) 2.0 (52) 3.8 (35) 3.4 (90) 6.9 (93) 4.8 (32) 
Heart rate (bpm) 62 (9) 61 (9) 61 (9) 61 (9) 63 (9) 62 (9) 
Body mass index (kg/m2) 25.1 (3.6) 23.7 (3.0) 24.1 (3.0) 25.2 (3.4) 26.7 (3.5) 27.8 (4.5) 
Physical activity (Baecke score) 6.9 (1.6) 6.9 (1.6) 6.8 (1.6) 6.9 (1.5) 6.9 (1.6) 6.8 (1.6) 
Depressive symptoms 11.8 (974) 9.8 (258) 10.5 (96) 12.8 (342) 12.6 (169) 16.3 (109) 
Antihypertensive medication 14.7 (1,209) 11.9 (315) 16.0 (147) 14.2 (381) 19.0 (255) 16.6 (111) 
Lipid-modifying medication 13.2 (1,089) 10.9 (288) 15.0 (138) 12.4 (331) 18.0 (241) 13.6 (91) 
Manifestations of vascular aging       
Carotid Distensibility coefficient (kPa-1 
x 10-3) 
22.0 (8.0) 22.6 (7.9) 22.3 (8.3) 21.8 (8.1) 21.0 (7.7) 21.7 (7.9) 
Carotid Young’s elastic modulus (kPa) 4.93 (2.22) 4.76 (2.06) 4.92 (2.23) 4.97 (2.28) 5.19 (2.34) 4.95 (2.24) 
Carotid intima-media thickness (μm) 638 (116) 628 (112) 641 (119) 640 (116) 650 (119) 646 (115) 
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Carotid diameter (mm)  7.16 (0.71) 7.10 (0.67) 7.18 (0.70) 7.13 (0.71) 7.31 (0.71) 7.16 (0.78) 
Resting hypertension 35.2 (2,904) 29.5 (779) 37.5 (344) 35.8 (958) 41.9 (562) 39.1 (261) 
Resting blood pressure 
   Systolic blood pressure (mmHg)  
 
131 (16) 
 
129 (16) 
 
132 (16) 
 
130 (16) 
 
133 (16) 
 
131 (16) 
   Diastolic blood pressure (mmHg) 76 (10) 75 (10) 76 (10) 75 (10) 77 (10) 76 (9) 
Exaggerated exercise blood pressure 44.8 (3,695) 40.5 (1,069) 45.0 (413) 45.6 (1,221) 50.4 (675) 47.5 (317) 
Exercise systolic blood pressure 
(mmHg) 
152 (19) 150 (19) 151 (19) 152 (19) 155 (19) 154 (19) 
Data are means (SD) or % (n). 
* Due to missing data, numbers or percentages for some variables do not sum to group totals or to 100%, respectively.  
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Table 2. Association between body silhouette trajectories and manifestations of vascular aging – results of intermediate quartiles 
Manifestations of 
vascular aging 
Body silhouette trajectories 
 Lean-increase Moderate-stable Lean-marked increase Heavy-stable 
 Odds ratio (95% confidence interval) 
Distensibility coefficient  
   Q3 vs Q4 1.14 (0.91;1.42) 1.25 (1.07;1.47) 1.19 (0.98;1.43) 1.22 (0.95;1.56) 
   Q2 vs Q4 1.17 (0.93;1.47) 1.28 (1.09;1.51) 1.32 (1.09;1.60) 1.25 (0.97;1.61) 
   Q1 vs Q4 0.99 (0.79;1.25) 1.39 (1.21;1.60) 1.52 (1.23;1.87) 1.50 (1.14;1.96) 
Young’s elastic modulus  
   Q2 vs Q1 1.13 (0.90;1.41) 1.26 (1.08;1.48) 1.17 (0.97;1.41) 1.17 (0.92;1.50) 
   Q3 vs Q1 1.08 (0.86;1.36) 1.24 (1.06;1.45) 1.21 (1.00;1.47) 1.15 (0.90;1.48) 
   Q4 vs Q1 0.91 (0.73;1.15) 1.23 (1.06;1.44) 1.27 (1.04;1.56) 1.37 (1.05;1.78) 
Intima-media thickness 
   Q2 vs Q1 1.01 (0.81;1.25) 1.01 (0.87;1.17) 1.15 (0.95;1.39) 1.48 (1.16;1.89) 
   Q3 vs Q1 1.13 (0.90;1.41) 1.12 (0.96;1.32) 1.33 (1.10;1.69) 1.32 (1.03;1.69) 
   Q4 vs Q1 1.00 (0.80;1.26) 1.39 (1.17;1.64) 1.67 (1.36;2.06) 1.83 (1.41;2.37) 
Diameter 
   Q2 vs Q1 1.05 (0.84;1.31) 1.14 (0.97;1.33) 1.32 (1.09;1.50) 1.71 (1.36;2.19) 
   Q3 vs Q1 1.11 (0.88;1.39) 1.17 (1.00;1.38) 1.32 (1.09;1.61) 1.63 (1.28;2.09) 
   Q4 vs Q1 0.86 (0.76;0.96) 1.31 (1.11;1.54) 1.71 (1.47;2.00) 2.10 (1.62;2.72) 
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Results adjusted for age, height, education, smoking, physical activity, dietary habits, heart rate, mean arterial pressure, use of antihypertensive 
medication, prior cardiovascular disease, diabetes, depressive symptoms and use of lipid-modifying medication. Lean-stable trajectory served as 
the reference in all analyses. For cut-off values of sex-specific quartiles, see the online supplemental material.  
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Table 3. Association between body silhouette trajectories and continuous measures of manifestations of vascular aging 
Trajectories Distensibility 
coefficient  
(kPa-1*10-3) 
Young’s elastic 
modulus (kPa) 
Intima-media 
thickness (μm) 
Diameter (mm) Resting systolic 
blood pressure 
(mmHg) 
Exercise systolic 
blood pressure 
(mmHg) 
 
Regression coefficient (95% confidence interval) 
Lean-stable Reference 
Lean-increase 0.2 (-0.3;0.8) 1 (-14;17) 2 (-6;10) -0.02 (-0.06;0.03) 1 (0;3) 0 (-1;2) 
Moderate-stable -0.6 (-1.9;-0.3) 16 (5;27) 13 (7;19) 0.06 (0.03;0.10) 1 (0;2) 2 (1;4) 
Lean-marked 
increase 
-0.9 (-1.4;-0.4) 22 (8;35) 18 (11;25) 0.14 (0.10;0.18) 2 (1;3) 3 (2;5) 
Heavy-stable -0.7 (-1.3;-0.1) 12 (-6;30) 23 (14;32) 0.16 (0.10;0.21) 2 (1;3) 4 (3;6) 
Results are adjusted for age, sex, height, education, smoking, physical activity, dietary habits, heart rate, prior cardiovascular disease, diabetes, 
depressive symptoms and use of lipid-modifying medication. Analyses with carotid distensibility coefficient, Young’s elastic modulus, intima-
media thickness and diameter as outcome were also adjusted for mean arterial pressure and use of antihypertensive medication.   
 
